71 Haynes St, Manchester, CT, 06040 · (860) 647-4780
Beds
123
FY 2025
Star rating
4 of 5
Patient survey: 2 of 5
Net patient revenue
$219.8M
FY 2025
Net income
-$63.6M
Patient care margin -24.6%
Discharges
6,138
Occupancy 56.0%
Clinicians
595
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $219.8M | $273.8M | -24.6% | -$63.6M | 6,138 | $6.5M | 18.3% | 20.1% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for COPD patients | 8.1% | US median 8.5% |
| Death rate for heart failure patients | 9.5% | US median 11% |
| Hospital-wide death rate within 30 days | 3.9% | US median 3.9% |
| Death rate for pneumonia patients | 12.6% | US median 15.2% |
| Death rate for stroke patients | 11.7% | US median 11.6% |
| Readmission rate for COPD | 20.9% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $222.7M | $250.6M | -12.5% | -$21.6M | 6,690 | $6.0M | 19.3% | 18.9% |
| 2023 | $208.0M | $248.5M | -19.5% | -$33.5M | 6,888 | $3.4M | 18.8% | 19.9% |
| 2022 | $208.4M | $222.6M | -6.8% | $7.1M | 6,547 | $3.6M | 20.9% | 20.8% |
| 2021 | $204.5M | $201.0M | 1.7% | $2.7M | 7,037 | $2.2M | 22.8% | 21.8% |
| 2020 | $183.6M | $190.6M | -3.8% | $13.5M | 6,352 | $2.0M | 26.0% | 14.1% |
| US median 19.8% |
| Readmission rate for heart failure | 22% | US median 21.3% |
| Readmission rate for pneumonia | 17.4% | US median 17.2% |
| Serious complications (patient safety composite) | 0.85 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.55 | US median 0.28 |
| Central line bloodstream infections (ratio to expected) | 0.00 | US median 0.48 |
| MRSA bloodstream infections (ratio to expected) | 0.00 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.29 | US median 0.40 |
| Doctors always communicated well | 71% | US median 79% |
| Nurses always communicated well | 72% | US median 80% |
| Patient survey summary star rating | 2 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 44% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 56% | US median 72% |
| Room and bathroom always clean | 68% | US median 73% |
| Patients who would definitely recommend the hospital | 58% | US median 71% |
| Patients who left the emergency department before being seen | 3% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 223 min | US median 148 min |
| Patients who got appropriate care for severe sepsis and septic shock | 44% | US median 65% |
| Healthcare workers given the flu vaccine | 89% | US median 79% |
| Stroke patients who got a brain scan within 45 minutes of arrival | 80% | US median 74% |
| 42 |
| $46,510.90 |
| $13,344.00 |
| $12,667.88 |
| DRG 193 SIMPLE PNEUMONIA AND PLEURISY WITH MCC | 39 | $49,045.26 | $10,941.54 | $9,867.73 |
| DRG 872 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | 38 | $34,857.63 | $7,781.00 | $7,681.44 |
| DRG 689 KIDNEY AND URINARY TRACT INFECTIONS WITH MCC | 31 | $45,320.71 | $11,074.39 | $8,838.11 |
| DRG 189 PULMONARY EDEMA AND RESPIRATORY FAILURE | 29 | $48,063.93 | $10,558.93 | $9,973.97 |
| DRG 378 GASTROINTESTINAL HEMORRHAGE WITH CC | 23 | $48,021.65 | $8,580.26 | $7,294.77 |
| DRG 690 KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC | 23 | $34,863.04 | $6,652.91 | $5,985.69 |
| DRG 640 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC | 23 | $60,044.22 | $14,637.65 | $10,642.23 |
| DRG 603 CELLULITIS WITHOUT MCC | 20 | $35,513.70 | $7,383.45 | $6,446.25 |
| DRG 682 RENAL FAILURE WITH MCC | 20 | $36,425.50 | $11,994.55 | $11,457.18 |
| DRG 683 RENAL FAILURE WITH CC | 20 | $41,947.65 | $7,868.35 | $6,629.69 |
| DRG 853 INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC | 18 | $136,076.44 | $43,667.83 | $40,556.82 |
| DRG 392 ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MCC | 15 | $40,817.93 | $6,288.87 | $5,662.18 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 8011 Comprehensive Observation Services | 412 | 356 | $2,416.20 | $2,090.36 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 68 | 50 | $1,439.58 | $1,219.56 |
| APC 5361 Level 1 Laparoscopy and Related Services | 62 | 61 | $5,048.67 | $4,357.80 |
| APC 5302 Level 2 Upper GI Procedures | 44 | 35 | $1,625.19 | $1,444.50 |
| APC 5374 Level 4 Urology and Related Services | 43 | 35 | $3,092.04 | $2,629.24 |
| APC 5115 Level 5 Musculoskeletal Procedures | 43 | 41 | $13,022.61 | $10,771.69 |
| APC 5491 Level 1 Intraocular Procedures | 31 | 20 | $2,065.15 | $1,751.67 |
| APC 5183 Level 3 Vascular Procedures | 27 | 26 | $2,833.02 | $2,405.01 |
| APC 5375 Level 5 Urology and Related Services | 25 | 23 | $4,506.97 | $3,917.51 |
| APC 5373 Level 3 Urology and Related Services | 19 | 17 | $1,808.67 | $1,516.28 |
| APC 5113 Level 3 Musculoskeletal Procedures | 17 | 17 | $2,874.79 | $2,373.24 |
| APC 5431 Level 1 Nerve Procedures | 17 | 17 | $1,716.08 | $1,406.61 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Siemens Medical Solutions USA, Inc. SHL.DE | 1 | $828K |
| Stryker Corporation SYK | 2 | $461K |
| Davol Inc. BDX | 1 | $276K |
| Bard Peripheral Vascular, Inc. BDX | 1 | $109K |
| Central Admixture Pharmacy Services, Inc. | 1 | $95K |
| Johnson & Johnson Health Care Systems Inc. JNJ | 1 | $80K |
| Arthrex, Inc. | 3 | $72K |
| Smith+Nephew, Inc. SNN | 1 | $71K |
| bioMerieux Inc | 1 | $50K |
| Teleflex LLC TFX | 1 | $20K |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Manchester Memorial Hospital is a for-profit short-term acute care hospital in Manchester, CT with 123 beds, part of Hartford Healthcare and a 4-star overall rating.
Manchester Memorial Hospital in Manchester, CT has 123 beds (fiscal year 2025 cost report); 249 beds are certified for Medicare. It discharged 6,138 inpatients that year, with 56.0% of its beds in use on average.
In fiscal year 2025 (ending 2025-12-31), Manchester Memorial Hospital reported net patient revenue of $219.8M and operating expenses of $273.8M, a margin on patient care of -24.6%. After other income and expenses its net income was -$63.6M (-27.1% of revenue), so it lost money that year.
Manchester Memorial Hospital is part of Hartford Healthcare, a health system with 9 hospitals based in Hartford, CT. It is a for-profit hospital.
Manchester Memorial Hospital has an overall rating of 4 out of 5 stars in the official hospital quality ratings. Patients rate it 2 out of 5 stars in the patient survey. 1 death rate measures are better and 0 worse than the national rate.
Yes, Manchester Memorial Hospital provides emergency services.
595 Medicare clinicians list Manchester Memorial Hospital as a hospital they work at, most often in Internal Medicine, Nurse Practitioner, Physician Assistant.
In 2024, Manchester Memorial Hospital had 793 Medicare inpatient stays in 24 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 261 stays; Medicare paid $16,230.79 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $2.1M in payments to Manchester Memorial Hospital as a teaching hospital ($2.1M general and - for research) from 16 companies.